8.48
18.07%
-1.87
시간 외 거래:
8.59
0.11
+1.30%
Shattuck Labs Inc 주식(STTK)의 최신 뉴스
Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients at the European Hematology Association (EHA) 2024 Congress
GlobeNewswire Inc.
What Makes Shattuck Labs (STTK) a New Buy Stock
Zacks Investment Research
Does Shattuck Labs (STTK) Have the Potential to Rally 34.17% as Wall Street Analysts Expect?
Zacks Investment Research
Shattuck Labs, Inc. (STTK) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire Inc.
Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024
GlobeNewswire Inc.
Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference
GlobeNewswire Inc.
Shattuck Labs Announces Participation in Upcoming March Conferences
GlobeNewswire Inc.
Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases
GlobeNewswire Inc.
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga
Shattuck Labs Announces Presentation at Upcoming 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Why Nxu Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket
Benzinga
Dow Jumps Over 200 Points; Federal Reserve Holds Interest Rates Steady
Benzinga
Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Crude Oil Gains 1.5%; Blackboxstocks Shares Plummet
Benzinga
US Stocks Mixed; Producer Prices Unchanged For November
Benzinga
Shattuck Labs Announces Positive Initial Topline Data from Ongoing Phase 1 A/B Dose Expansion Clinical Trial of SL-172154 with Azacitidine in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients
GlobeNewswire Inc.
Wall Street Breakfast: The Week Ahead
Seeking Alpha
Shattuck Labs to Host Investor Call and Webcast to Share Initial Clinical Trial Data from Phase 1A/B Dose-Expansion Cohorts in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53m Acute Myeloid Leukemia (AML) and Review of Dose-Escalation Data from the American Society of Hematology (ASH) 2023 Annual Meeting on December 13, 2023
GlobeNewswire Inc.
Shattuck Labs Announces Participation in Upcoming 6th Annual Evercore ISI HealthCONx Conference
GlobeNewswire Inc.
자본화:
|
볼륨(24시간):